Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06671886 · ClinicalTrials.gov registry record · NA
NAFLD Clinical Care Pathway
A NA study of NAFLD and MASLD, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT06671886 is a NA study of NAFLD and MASLD that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 32 participants, below the 164-participant average among 26 other NAFLD trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06671886, a NA study of NAFLD and MASLD, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Non-alcoholic fatty liver disease (NAFLD) is a new condition that has become the most common chronic liver disease in the world and a main cause of liver cirrhosis, liver failure and liver cancer. Obesity and diabetes, conditions that are very common among Veterans are the main risk factors for NAFLD. Therefore, the burden of NAFLD and its complications among Veterans is substantial. However, most VA patients with NAFLD are undiagnosed and untreated, and their care is not consistent with practice guidelines. The NAFLD Clinical Care Pathway (NCCP) intervention seeks to close this major gap in the care of Veterans by automatically identifying patients at risk of NAFLD, calculating their risk scores of having severe NAFLD, and educating the primary care providers on the diagnosis and treatment of NAFLD. This clinical trial will test the benefit of this NCCP intervention against usual care in increasing the rates of NAFLD diagnosis as well as referral to and enrollment in appropriate treatment. The study will also identify barriers and promotors of future NCCP implementation.
Interventions
- BEHAVIORAL E-trigger
Study Locations (1)
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-02-02 |
| Est. Completion | 2028-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06671886
The ClinicalTrials.gov registry entry for NCT06671886 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 26 other NAFLD trials with a reported enrollment target (80% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with NAFLD appearing as the primary indexed condition, and to 1 intervention - of which E-trigger is the first listed.
NCT06671886 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06671886 about?
NCT06671886 is a clinical study titled "NAFLD Clinical Care Pathway". Non-alcoholic fatty liver disease (NAFLD) is a new condition that has become the most common chronic liver disease in the world and a main cause of liver cirrhosis, liver failure and liver cancer. Obesity and diabetes, conditions that are very common among Veterans are the main risk factors for NAFL...
What is the current status of trial NCT06671886?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-02-02. Estimated completion is 2028-11-13.
What conditions does trial NCT06671886 study?
This clinical trial studies the following conditions: NAFLD, MASLD.
What interventions are being tested in trial NCT06671886?
The interventions under investigation include: E-trigger (BEHAVIORAL).
Who is sponsoring clinical trial NCT06671886?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06671886 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NAFLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reversal of Lipid-Induced Insulin Resistance
RECRUITING · NA
-
NASH AMPK Exercise Dosing (AMPED) Trial
RECRUITING · NA
-
Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD
ACTIVE NOT RECRUITING · NA
-
An Imaging-based Quantitative Biomarker Assay for NAFLD in Children
ACTIVE NOT RECRUITING · NA
-
The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study)
COMPLETED · NA
-
Healthy Liver - Healthy Brain
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.